Short interest in Xilio Therapeutics Inc (NASDAQ:XLO) decreased during the last reporting period, falling from 384.09K to 213.07K. This put 0.56% of the company's publicly available shares short.

Short interest for Xilio Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Xilio Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 362.70K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.